marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q2
added 08-15-2024
Titan Pharmaceuticals Financial Ratios 2011-2024 | TTNP
Annual Financial Ratios Titan Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.9 | -0.1 | -1.2 | - | -0.4 | -1.6 | -2.0 | 16.4 | -6.3 | -18.8 | 6.1 | -8.1 | -4.7 |
P/S |
28.4 | 0.9 | 6.6 | 2.1 | 1.7 | 2.4 | 133.1 | 5.6 | 42.4 | 12.4 | 5.7 | 17.3 | 17.4 |
EPS |
-7.4 | -15.2 | - | -2.0 | -0.7 | -1.6 | -0.7 | 0.2 | -0.6 | -0.0 | 0.1 | -0.2 | -0.3 |
EV (Enterprise Value) |
-82.1 K | 275 K | 6.93 M | 9.45 M | 9.06 M | 12.3 M | 29.1 M | 75.5 M | 69.2 M | 42 M | 60.2 M | 153 M | 95.8 M |
EBITDA per Share |
-9.53 | -14.9 | -0.92 | -2.16 | -21.7 | -19.8 | -120 | 41 | -57.5 | -32.9 | -9.45 | -124 | -175 |
EV/EBITDA |
-0.7 | -0.8 | -0.3 | -1.2 | -2.0 | 14.8 | -9.8 | -9.5 | -60.7 | -14.0 | -7.4 | ||
PEG |
-0.0 | -0.0 | 0.01 | - | -0.05 | -0.02 | 0.01 | 0.11 | 0.03 | 0.15 | 0.04 | -0.7 | 0.02 |
P/B |
0.8 | 0.4 | 2.0 | 2.9 | 4.3 | 2.1 | 33.4 | 6.4 | 10.1 | 5.3 | 10.3 | -5.3 | -3.5 |
P/CF |
-0.7 | -0.1 | -1.3 | -0.6 | -0.4 | -1.6 | -2.2 | 13.7 | -9.3 | -7.7 | -5.9 | 181.8 | -4.8 |
ROE % |
-83.85 | -748.79 | -170.81 | - | -1148.50 | -132.09 | -1669.43 | 38.93 | -161.36 | -27.91 | 168.59 | 65.63 | 75.72 |
ROA % |
-68.87 | -251.50 | -109.78 | - | -172.84 | -64.02 | -160.66 | 27.51 | -84.89 | -11.52 | 52.71 | -61.14 | -148.80 |
ROCE % |
-109.56 | -750.92 | -182.06 | -190.24 | -284.43 | -77.65 | -326.55 | 31.45 | -80.14 | -24.49 | -11.76 | -243.74 | -206.24 |
Current Ratio |
5.6 | 1.5 | 2.8 | 1.7 | 2.3 | 3.9 | 1.9 | 3.7 | 2.5 | 2.9 | 1.6 | 1.1 | 1.9 |
DSO |
81.3 | 48.5 | 119.1 | - | 100.4 | 113.4 | 110.3 | 86.9 | 920.3 | 397.2 | 167.8 | 238.3 | 333.8 |
DIO |
- | - | 569.5 | 253.6 | 282.8 | 856.2 | - | - | - | - | - | - | - |
DPO |
- | - | 1878.2 | 969.0 | 397.0 | 1035.3 | - | - | - | - | - | - | - |
Operating Cycle |
81.3 | 48.5 | 688.6 | 253.6 | 383.2 | 969.6 | - | - | - | - | - | - | - |
Cash Conversion Cycle |
81.3 | 48.5 | -1189.6 | -715.3 | -13.8 | -65.7 | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Titan Pharmaceuticals
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-2.29 | -1.24 | - | -0.02 | -2.11 | -2.23 | - | -0.18 | -0.18 | -0.24 | - | - | -0.17 | -0.28 | - | -0.05 | -0.05 | -0.07 | -0.08 | -0.18 | -0.38 | -0.34 | -0.29 | -0.64 | -0.25 | -0.74 | -1.04 | -0.2 | -0.16 | -0.14 | -0.11 | -0.12 | 0.58 | -0.09 | -0.11 | -0.09 | -0.11 | -0.24 | -0.02 | 0.04 | -0.01 | -0.02 | - | -0.01 | 0.06 | 0.08 | - | -0.12 | -0.03 | -0.09 | -0.05 | -0.01 | -0.12 | -0.08 |
EBITDA per Share |
- | -1.24 | - | - | - | -2.2 | - | -0.17 | -0.17 | -0.23 | - | -0.18 | -0.22 | -0.28 | - | -0.3 | -0.47 | -0.69 | - | -238 | -0.35 | -0.32 | - | -442 | -0.02 | -0.11 | - | -0.18 | -0.16 | -0.16 | - | -0.11 | 0.6 | -0.09 | - | -0.08 | -0.05 | -0.08 | - | -0.03 | - | -0.01 | - | - | - | - | - | -0.04 | -0.03 | -0.06 | - | - | - | - |
ROE % |
-78.13 | 127.66 | 686.09 | 611.78 | 541.62 | 344.79 | -149.98 | -175.53 | -126.76 | -102.53 | -71.22 | -210.85 | -324.94 | -437.14 | -429.13 | -704.15 | -760.12 | -991.38 | -1148.50 | -924.78 | -759.11 | -409.17 | -132.09 | -507.86 | -966.96 | -1356.92 | -1669.43 | -1260.00 | -790.83 | -297.72 | 38.93 | 23.75 | 17.76 | -105.30 | -161.36 | -134.03 | -99.87 | -77.01 | -27.91 | -26.04 | -54.24 | 43.46 | 168.59 | 173.43 | 227.96 | 147.50 | 65.63 | 78.86 | 48.21 | 75.57 | 75.72 | 4.00 | 34.81 | 22.47 |
ROA % |
-70.83 | -218.03 | -275.96 | -317.99 | -356.65 | -190.92 | -96.25 | -116.12 | -93.95 | -78.96 | -53.58 | -114.56 | -155.68 | -198.47 | -187.42 | -228.81 | -197.26 | -194.45 | -172.84 | -156.31 | -141.38 | -92.97 | -64.02 | -80.26 | -112.81 | -145.40 | -160.66 | -132.03 | -99.00 | 3.65 | 27.51 | 22.71 | 23.14 | -57.92 | -84.89 | -69.89 | -52.86 | -39.73 | -11.52 | -10.39 | -20.04 | 11.49 | 52.71 | 52.72 | 26.66 | -7.77 | -61.14 | -88.38 | -63.97 | -125.44 | -148.80 | -7.87 | -68.41 | -44.16 |
ROCE % |
-120.07 | 85.43 | 672.15 | 597.70 | 548.59 | 351.92 | -149.75 | -175.21 | -126.21 | -109.70 | -78.41 | -112.27 | -120.68 | -139.91 | -135.59 | -406.56 | -643.67 | -938.54 | -910.68 | -939.25 | -696.86 | -365.53 | -73.17 | -548.08 | -994.42 | -1407.58 | -1298.48 | -1318.31 | -863.23 | -349.41 | 57.59 | 31.81 | 25.86 | -81.06 | -64.51 | -73.08 | -55.87 | -46.63 | -25.80 | -28.03 | -21.68 | -20.36 | -4.32 | 7.17 | 20.88 | 33.46 | 34.28 | 44.03 | 42.28 | 55.68 | 48.51 | 9.75 | 20.92 | 17.84 |
Current Ratio |
12.2 | 11.9 | 5.6 | 5.4 | 0.4 | 0.9 | 1.5 | 2.3 | 3.1 | 4.2 | 2.8 | 4.5 | 4.2 | 3.6 | 1.8 | 1.8 | 1.8 | 1.8 | 1.2 | 1.2 | 1.2 | 1.2 | 1.9 | 1.9 | 1.9 | 1.9 | 1.1 | 1.1 | 1.1 | 1.1 | 3.4 | 3.4 | 3.4 | 3.4 | 2.1 | 2.1 | 2.1 | 2.1 | 1.7 | 1.7 | 1.7 | 1.7 | 1.4 | 1.4 | 1.4 | 1.4 | 0.5 | 0.5 | 0.5 | 0.5 | 0.3 | 0.3 | 0.3 | 0.3 |
DSO |
- | - | - | 399.2 | 9.3 | 20.5 | - | 72.0 | 97.0 | 78.4 | - | 63.6 | 51.4 | 85.8 | - | 79.2 | 64.6 | 53.6 | 53.6 | 95.7 | 180.5 | 131.8 | 128.2 | 96.1 | 59.4 | 77.3 | 102.3 | 148.3 | 77.0 | 4165.6 | 9351.8 | 12589.0 | 21.8 | - | - | - | 505.8 | 409.7 | 397.0 | 397.4 | 397.4 | 440.0 | 482.6 | 200.0 | 200.0 | 83.5 | 130.1 | 345.2 | 311.7 | 300.6 | 240.2 | 335.4 | 488.4 | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | 59.1 | 177.9 | 226.5 | - | - | - | - | - | 484.4 | 370.2 | 339.2 | - | 647.0 | 1645.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | 189.2 | 618.8 | 838.3 | - | - | - | - | - | 680.0 | 519.7 | 439.3 | - | 782.3 | 1989.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | 399.2 | 9.3 | 20.5 | - | 72.0 | 97.0 | 78.4 | - | 122.8 | 229.3 | 312.2 | - | 79.2 | 64.6 | 53.6 | 53.6 | 580.1 | 550.7 | 471.0 | 128.2 | 743.0 | 1704.5 | 77.3 | 102.3 | 148.3 | 77.0 | 4165.6 | 9351.8 | 12589.0 | 21.8 | - | - | - | 505.8 | 409.7 | 397.0 | 397.4 | 397.4 | 440.0 | 482.6 | 200.0 | 200.0 | 83.5 | 130.1 | 345.2 | 311.7 | 300.6 | 240.2 | 335.4 | 488.4 | - |
Cash Conversion Cycle |
- | - | - | 399.2 | 9.3 | 20.5 | - | 72.0 | 97.0 | 78.4 | - | -66.4 | -389.5 | -526.0 | - | 79.2 | 64.6 | 53.6 | 53.6 | -99.9 | 31.0 | 31.7 | 128.2 | -39.3 | -284.7 | 77.3 | 102.3 | 148.3 | 77.0 | 4165.6 | 9351.8 | 12589.0 | 21.8 | - | - | - | 505.8 | 409.7 | 397.0 | 397.4 | 397.4 | 440.0 | 482.6 | 200.0 | 200.0 | 83.5 | 130.1 | 345.2 | 311.7 | 300.6 | 240.2 | 335.4 | 488.4 | - |
All numbers in USD currency